Mr. Skarpelos, a director of Anavex®, is a self-employed investor with 17 years of experience working with private and public companies.  For the past 10 years, he has been focused on biotechnology companies involved in drug discovery and drug development projects.  Mr. Skarpelos was engaged as a consultant to Anavex®Life Sciences for one year effective August 2, 2010.  His experience has led to relationships with researchers at academic institutes in Europe and North America.  Mr. Skarpelos is a founder of Anavex®Life Sciences, and is its largest shareholder. Mr. Skarpelos, a director of Anavex®, is a self-employed investor with 17 years of experience working with private and public companies.  For the past 10 years, he has been focused on biotechnology companies involved in drug discovery and drug development projects.  Mr. Skarpelos was engaged as a consultant to Anavex®Life Sciences for one year effective August 2, 2010.  His experience has led to relationships with researchers at academic institutes in Europe and North America.  Mr. Skarpelos is a founder of Anavex®Life Sciences, and is its largest shareholder.

Biotechnology